phaware® Launches Special Series of Podcast Episodes Spotlighting the Future of PH-ILD Treatment and Innovation

Liquidia, Pulmovant, and Gossamer Bio Partner with Nonprofit to Showcase Cutting-Edge Clinical Trials and Breakthrough Therapies

LOS ANGELES, April 1, 2025 /PRNewswire/ -- phaware® global association is set to launch an exclusive series of special edition episodes of its acclaimed "I'm Aware That I'm Rare: the phaware® podcast," delving into the fast-evolving world of Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD). Kicking off on April 7th, this captivating series will feature top-tier PH-ILD experts exploring clinical breakthroughs and transformative therapies that are reshaping the treatment landscape.

Explore the Latest Innovations In PH-ILD
Sponsored by Liquidia, Pulmovant, and Gossamer Bio, this series of episodes highlights the cutting-edge research propelling PH-ILD advancements while emphasizing "why early intervention matters" in optimizing patient outcomes.

Featured Medical Experts Include:
Drs. Rajan Saggar (UCLA), Ronald Zolty (UNMC), Raj Parikh (Hartford Hospital), Ioana Preston (Lahey Hospital), Richard Channick (UCLA), Jean Elwing (University of Cincinnati), and Marc Simon (UCSF).

Championing a New Era in PH-ILD Care
"Raising awareness of pulmonary hypertension associated with interstitial lung disease (or PH-ILD) alongside our advocacy partners is a critical component of our collective effort to ensure patients, caregivers and physicians feel informed and empowered," said Dr. Roger Jeffs, CEO of Liquidia. "We are grateful to join hands with phaware on this important awareness campaign, and we look forward to helping ensure this vastly underserved patient population can be properly diagnosed and treated effectively."   

"We are proud to support the innovative work of phaware global association and its new PH-ILD podcast initiative, which brings forward stories and expert opinions to educate and empower patients about this life-threatening and often-misdiagnosed disease," said Drew Fromkin, Chief Executive Officer of Pulmovant. "Podcasts are an excellent channel for increasing disease awareness and fostering community among patients, families, and their providers. Pulmovant is pleased to be at the forefront of this important initiative alongside some of our industry colleagues."

What Listeners Can Expect:

• In-Depth Clinical Insights: A closer look at ongoing and upcoming clinical trials shaping the future of PH-ILD.
• Therapies on the Horizon: Insight into groundbreaking treatments approaching FDA approval.
• Expert Perspectives: Exclusive commentary from leading voices defining the next chapter in PH-ILD care.

A Milestone Moment for PH-ILD Awareness
"These episodes represents a pivotal moment for the PH-ILD community," said Steve Van Wormer, Co-Founder of phaware® and Executive Producer of the "I'm Aware That I'm Rare" podcast. "We are thrilled to bring together such an distinguished panel of experts to discuss how research and innovation are driving meaningful change for patients worldwide."

Episodes Launch April 7th
New episodes will drop every Monday on all major podcast platforms, including Spotify, Apple Podcasts, and YouTube Music. Listen, Like, and Subscribe at: www.phawarepodcast.com.

About phaware® global association
phaware® global association is a nonprofit organization dedicated to raising global awareness and accelerating research for pulmonary hypertension through innovative technology. Learn more at www.phaware.global.

Media Contact:
Steve Van Wormer
phaware® global association
[email protected]
818.395.3529

SOURCE phaware global association